Barclays maintains an 'Equalweight' on Medtronic, Inc. (NYSE: MDT) price target of $45.00 (from $41.00).

Analyst, Matthew Taylor, said ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE